[ad_1]
go through Hong Kong Economic Times July 30, 2024
originalPublished in Hong Kong Economic Times Financial NewsEJ Tech Innovation Lab“
In the U.S. Food and Drug Administration (FDA)Early Feasibility StudyWith approval,Texas Heart Institute (THI)and clinical-stage medical device companiesVivacothe first time in humansImplantationThe magnetically suspended total artificial heart (TAH) BiVACOR, which claims to have no friction or mechanical wear, will later include another four patients in the study. BiVACOR is a titanium alloy biventricular rotary blood pump, which claims to be manufactured using the same technology as high-speed rail and can pump blood at a rate of 12 liters per minute, enough to meet the exercise needs of adult men. The design uses magnetic levitation technology, has no valves or curved ventricles, and has a longer service life, which is expected to buy time for patients with end-stage heart failure to wait for organ transplants.
Support EJ Tech
If you want to submit articles, report information, issue press releases or interview notices,Click here to contact us.
[ad_2]
Source link
